Global Molecular Diagnostics Market, 2020-2026

March 2020 | 97 pages | ID: G8A71702E9E5EN
Gen Consulting Company

Abstracts

The global molecular diagnostics market size was valued at $12,134.69 million in 2019 and is projected to reach $21,716.83 million by 2026, registering a CAGR of 8.67% from 2020 to 2026. The molecular diagnostics market is segmented on the basis of product, technology, application, and region. The report offers a breakdown of market shares by product, including Instruments, Kits & Reagents. Based on technology, the market for molecular diagnostics is segmented into Polymerase Chain Reaction (PCR), Microarrays, In Situ Hybridization (ISH), Next-generation Sequencing (NGS), Others. By application, the molecular diagnostics market is classified into Hospitals & Clinics, Diagnostic Centers, Research Institutes. On the basis of region, the molecular diagnostics industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Product:

• Instruments
• Kits & Reagents

By Technology:

• Polymerase Chain Reaction (PCR)
• Microarrays
• In Situ Hybridization (ISH)
• Next-generation Sequencing (NGS)
• Others

By Application:

• Hospitals & Clinics
• Diagnostic Centers
• Research Institutes

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.

• North America (U.S., Canada, Mexico, etc.)
• Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
• Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
• South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the molecular diagnostics market. Some of the leading players profiled in the report include:

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• bioM?rieux S.A.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Illumina, Inc.
• QIAGEN N.V.
• Siemens AG
• Thermo Fisher Scientific, Inc.

*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective

• To analyze and forecast the market size of global molecular diagnostics market.
• To classify and forecast global molecular diagnostics market based on product, technology, application, and region.
• To identify drivers and challenges for global molecular diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global molecular diagnostics market.
• To conduct pricing analysis for global molecular diagnostics market.
• To identify and analyze the profile of leading players operating in global molecular diagnostics market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:

• Manufacturers of molecular diagnostics
• Raw material suppliers
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to molecular diagnostics

Contents

PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Consumers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitute Products and Services
  4.5.5 Degree of Competition

PART 5. GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY PRODUCT

5.1 Market Overview
5.2 Instruments
  5.2.1 Market Size and Forecast
5.3 Kits & Reagents
  5.3.1 Market Size and Forecast

PART 6. GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY

6.1 Market Overview
6.2 Polymerase Chain Reaction (PCR)
  6.2.1 Market Size and Forecast
6.3 Microarrays
  6.3.1 Market Size and Forecast
6.4 In Situ Hybridization (ISH)
  6.4.1 Market Size and Forecast
6.5 Next-generation Sequencing (NGS)
  6.5.1 Market Size and Forecast
6.6 Others
  6.6.1 Market Size and Forecast

PART 7. GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION

7.1 Market Overview
7.2 Hospitals & Clinics
  7.2.1 Market Size and Forecast
7.3 Diagnostic Centers
  7.3.1 Market Size and Forecast
7.4 Research Institutes
  7.4.1 Market Size and Forecast

PART 8. GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY GEOGRAPHY

8.1 Overview
  8.1.1 Market Size and Forecast
8.2 North America
  8.2.1 Market Size and Forecast
  8.2.2 North America: Molecular Diagnostics Market by Country
    8.2.2.1 United States
    8.2.2.2 Canada
    8.2.2.3 Mexico
8.3 Europe
  8.3.1 Market Size and Forecast
  8.3.2 Europe: Molecular Diagnostics Market by Country
    8.3.2.1 Germany
    8.3.2.2 France
    8.3.2.3 United Kingdom
    8.3.2.4 Italy
    8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
  8.4.1 Market Size and Forecast
  8.4.2 Asia-Pacific: Molecular Diagnostics Market by Country
    8.4.2.1 China
    8.4.2.2 India
    8.4.2.3 Japan
    8.4.2.4 South Korea
    8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
  8.5.1 Market Size and Forecast
  8.5.2 MEA: Molecular Diagnostics Market by Country
    8.5.2.1 Saudi Arabia
    8.5.2.2 South Africa
    8.5.2.3 Turkey
8.6 South America
  8.6.1 Market Size and Forecast
  8.6.2 South America: Molecular Diagnostics Market by Country
    8.6.2.1 Brazil
    8.6.2.2 Argentina
    8.6.2.3 Rest of South America

PART 9. COMPETITIVE LANDSCAPE

9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

PART 10. KEY COMPETITOR PROFILES

10.1 Abbott Laboratories
10.2 Agilent Technologies, Inc.
10.3 Becton, Dickinson and Company
10.4 bioM?rieux S.A.
10.5 Bio-Rad Laboratories, Inc.
10.6 Danaher Corporation
10.7 F. Hoffmann-La Roche AG
10.8 Hologic, Inc.
10.9 Illumina, Inc.
10.10 QIAGEN N.V.
10.11 Siemens AG
10.12 Thermo Fisher Scientific, Inc.
*LIST IS NOT EXHAUSTIVE

PART 11. PATENT ANALYSIS

11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis

DISCLAIMER

About

ABOUT GEN CONSULTING COMPANY